PharmaShots | Incisive News in 3 Shots

Subscribe Now

Divest

Lonza to Divest Specialty Ingredients Business to Bain Capital and Cinven for $4.7B

Lonza to Divest Specialty Ingredients Business to Bain Capital and Cinven for $4.7B

February 10, 2021

Takeda to Divest TachoSil to Corza Health for ~$416M

Takeda to Divest TachoSil to Corza Health for ~$416M

September 16, 2020

Takeda to Divest its Consumer Health Unit to Blackstone for $2.3B in Japan

Takeda to Divest its Consumer Health Unit to Blackstone for $2.3B in Japan

August 24, 2020

Takeda to Divest OTC and Select Non-core Assets to Celltrion for ~ $278M

Takeda to Divest OTC and Select Non-core Assets to Celltrion for ~ $278M

June 12, 2020

Takeda to Divest Select OTC and Non-Core Assets in Europe to Orifarm for $670M

Takeda to Divest Select OTC and Non-Core Assets in Europe to Orifarm for $670M

April 24, 2020

Takeda to Divest a Portfolio of Select OTC and Non-Core Assets to Hypera Pharma in Latin America for $825M

Takeda to Divest a Portfolio of Select OTC and Non-Core Assets to Hypera Pharma in Latin America for $825M

March 2, 2020

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us